You're reading the free version. Trader adds the live tape and alerts.
Start tracking
HALO Exercise Disclosure
Snyder Mark Howard · SEC Form 4 · Filed Jun 15, 2026
Exercise
Calculated transaction value
$0
Snyder Mark Howard SVP, Chief Legal Officer
HALO
Transaction date
Jun 12, 2026
Public filing date
Jun 15, 2026
Filing lag
Filed 3 days later
HALO daily price context
Close on/before transaction
$69.5
Jun 12, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Stock Units on Common Stock
- Quantity / price
- 5,034 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001159036-26-000077
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$188.69K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Halozyme Therapeutics, Inc. HALO | Disposition | Jun 12, 2026 | $188.69K |
| Halozyme Therapeutics, Inc. HALO | Exercise | Jun 12, 2026 | $0 |
| Halozyme Therapeutics, Inc. HALO Current | Exercise | Jun 12, 2026 | $0 |